Publikationen, an denen er mitarbeitet Irene Rivero Calle (31)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  3. Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338

  4. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia

    Genes and Diseases, Vol. 11, Núm. 3

  5. Whole exome sequencing identifies new susceptibility candidates underlying community-acquired pneumonia

    Genes and Diseases, Vol. 11, Núm. 6

2023

  1. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract

    Journal of Infection, Vol. 87, Núm. 6, pp. 538-550

  2. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain

    Pediatric Allergy and Immunology, Vol. 34, Núm. 10

  3. Chatting with ChatGPT to learn about safety of COVID-19 vaccines–A perspective

    Human Vaccines and Immunotherapeutics

  4. Emergency medical services utilisation among febrile children attending emergency departments across Europe: an observational multicentre study

    European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 3939-3947

  5. Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection

    Antiviral research, Vol. 220, pp. 105760

  6. Music compensates for altered gene expression in age-related cognitive disorders

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity

    Environmental Research, Vol. 210

  2. CD14 and Related Genes in Respiratory Morbidity After Respiratory Syncytial Virus Infection

    The Journal of infectious diseases, Vol. 226, Núm. 7, pp. 1295-1297

  3. Case Report: Everolimus reduced bone turnover markers but showed no clinical benefit in a patient with severe progressive osseous heteroplasia

    Frontiers in Pediatrics, Vol. 10

  4. Characterisation of the blood RNA host response underpinning severity in COVID-19 patients

    Scientific Reports, Vol. 12, Núm. 1

  5. Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain

    Environmental Research, Vol. 215

  6. Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 7

  7. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative

    PLoS genetics, Vol. 18, Núm. 11, pp. e1010367

  8. Guideline adherence in febrile children below 3 months visiting European Emergency Departments: an observational multicenter study

    European Journal of Pediatrics, Vol. 181, Núm. 12, pp. 4199-4209

  9. Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection: The EPIRESVi Study

    Frontiers in Immunology, Vol. 13